Federal Health Minister Tony Clement joined the Canadian Lung Association to announce the development of a national action plan to improve the respiratory health of Canadians.
India is among six developing countries who have been awarded grants to establish capacity to manufacture influenza vaccine so that it is readily available in case a pandemic breaks out, the United Nations health agency has announced.
New research suggests that statins may be useful when treating infection-related influenza and pneumonia.
Novartis has received a positive opinion supporting European U nion approval of its cell culture-derived seasonal influenza vaccine Optaflu?, which is aiming to become the first influenza vaccine to utilize a mammalian cell line, rather than chicken eggs, for antigen production.
Roche announces several new research initiatives to further study the use of Tamiflu against the evolving H5N1 avian influenza virus and outlined the future production strategy for Tamiflu.
Solvay announced that its dossier for intravenous tedisamil (intended brand name: PULZIUM? IV), a new chemical entity coming from Solvay Pharmaceuticals R&D laboratories, has been filed for approval by the US Food and Drug Administration (FDA) as well as by the authorities of European U nion countries.
Roche announces several new research initiatives to further study the use of Tamiflu against the evolving H5N1 avian influenza virus and outlined the future production strategy for Tamiflu.
A Medical College of Wisconsin and Children?s Research Institute team in Milwaukee has created a free, searchable genetic database that will significantly improve diagnostic testing and genetic tracking of human and animal influenza viruses. The site, which is automatically updated weekly, will also facilitate rapid response as new virus strains emerge to cause either annual epidemics or the next pandemic.
Aiming to ensure that in the event of a flu pandemic, all countries will have access to sufficient doses of influenza vaccine, six developing States are being awarded grants to establish their capacity to manufacture them, the United Nations World Health Organization (WHO) announced.
As part of a concerted effort to ensure more equitable access to a potential pandemic influenza vaccine, six developing countries are being awarded grants to establish in-country manufacturing capacity for influenza vaccine.